Literature DB >> 29472673

No studies.

K Altundag.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29472673     DOI： 10.1038/sj.bdj.2018.133

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  2 in total

Review 1.  The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.

Authors:  Onder Tonyali; Cagatay Arslan; Kadri Altundag
Journal:  Expert Opin Pharmacother       Date:  2010-11       Impact factor: 3.889

2.  MRONJ risk of adjuvant bisphosphonates in early stage breast cancer.

Authors:  V Patel; J Mansi; S Ghosh; J Kwok; M Burke; D Reilly; N Nizarali; C Sproat; K Chia
Journal:  Br Dent J       Date:  2017-12-15       Impact factor: 1.626
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.